Featured Author Podcast: Danavorexton Promotes Respiration and Wakefulness
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Featured Author Podcast: Danavorexton Promotes Respiration and Wakefulness
-
Narrated by:
-
By:
About this listen
Moderator: James P. Rathmell, M.D.
Participants: Rebecca L. Wu, M.D. and Max B. Kelz, M.D., Ph.D.
Articles Discussed:
TAK-925 (danavorexton), an Orexin Receptor 2 Agonist, Reduces Opioid-Induced Respiratory Depression and Sedation Without Affecting Analgesia in Healthy Adult Males
Alluring Potential to Accelerate Emergence and Ameliorate Opioid-induced Respiratory Depression without Antagonizing Analgesia: Danavorexton Enters the Anesthetic Landscape
Transcript
activate_mytile_page_redirect_t1
What listeners say about Featured Author Podcast: Danavorexton Promotes Respiration and Wakefulness
Average Customer RatingsReviews - Please select the tabs below to change the source of reviews.
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.